BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 22672477)

  • 41. Impact of diabetes mellitus on transplantation.
    Waki K
    Clin Transpl; 2004; ():357-77. PubMed ID: 16704163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintenance immunosuppression.
    Takemoto SK
    Clin Transpl; 2000; ():481-95. PubMed ID: 11512360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
    Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
    Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
    Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
    Opelz G; Döhler B
    Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A; Oei E; Vathsala A
    Transplant Proc; 2012 Jan; 44(1):193-9. PubMed ID: 22310613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
    El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 54. Factors affecting graft and patient survival after live donor kidney transplantation in the UK.
    Fuggle SV; Allen JE; Johnson RJ; Collett D; Mason PD; Dudley C; Rudge CJ; Bradley JA; Watson CJ;
    Transplantation; 2010 Mar; 89(6):694-701. PubMed ID: 20308863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation?
    Mandal AK; Snyder JJ; Gilbertson DT; Collins AJ; Silkensen JR
    Transplantation; 2003 Feb; 75(4):494-500. PubMed ID: 12605117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Hodge EE;
    Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
    Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
    Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
    Tran TH; Döhler B; Heinold A; Scherer S; Ruhenstroth A; Opelz G
    Transplantation; 2011 Aug; 92(4):419-25. PubMed ID: 21743387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.